Physician profile
Sami E Constantine
NPI 1811004112
$2,946.78
in general payments reported to CMS, 2019-2025
20 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $805 · 2021: $507 · 2022: $215 · 2023: $478 · 2024: $78.88 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.33 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $779.08 | 2019-2022 | |
| Coloplast Corp | $588.65 | 2020 | |
| Mayne Pharma Commercial LLC | $388.50 | 2023-2025 | |
| Astellas Pharma US INC | $267.18 | 2023-2025 | Veozah |
| Organon LLC | $121.22 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $115.81 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $113.50 | 2019 | |
| Avion Pharmaceuticals | $101.42 | 2020-2023 | Balcoltra |
| Duchesnay USA Incorporated | $98.00 | 2019 | |
| Mylan Pharmaceuticals INC. | $95.72 | 2020-2022 | |
| Hologic Sales and Service, LLC | $67.69 | 2019-2021 | |
| Millicent US INC | $42.30 | 2023 | Femring, Intrarosa |
| Agile Therapeutics, INC. | $33.23 | 2021 | |
| Therapeuticsmd, INC. | $30.17 | 2019-2020 | |
| Pfizer INC. | $29.41 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $20.79 | 2023 | Myfembree |
| Kedrion Biopharma INC. | $15.82 | 2019 | |
| Mission Pharmacal Company | $14.15 | 2020 | |
| Scynexis, INC. | $12.88 | 2021 | |
| Allergan, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Constantine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.